These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition. Vaquero J; Monte MJ; Dominguez M; Muntané J; Marin JJ Biochem Pharmacol; 2013 Oct; 86(7):926-39. PubMed ID: 23928191 [TBL] [Abstract][Full Text] [Related]
23. Unmetabolized fenofibrate, but not fenofibric acid, activates AMPK and inhibits the expression of phosphoenolpyruvate carboxykinase in hepatocytes. Murakami R; Murakami H; Kataoka H; Cheng XW; Takahashi R; Numaguchi Y; Murohara T; Okumura K Life Sci; 2010 Oct; 87(15-16):495-500. PubMed ID: 20849861 [TBL] [Abstract][Full Text] [Related]
24. FXR, a multipurpose nuclear receptor. Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160 [TBL] [Abstract][Full Text] [Related]
25. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome. Duran-Sandoval D; Cariou B; Fruchart JC; Staels B Biochimie; 2005 Jan; 87(1):93-8. PubMed ID: 15733743 [TBL] [Abstract][Full Text] [Related]
26. Regulation of energy metabolism by long-chain fatty acids. Nakamura MT; Yudell BE; Loor JJ Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249 [TBL] [Abstract][Full Text] [Related]
28. Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor. Yang F; Huang X; Yi T; Yen Y; Moore DD; Huang W Cancer Res; 2007 Feb; 67(3):863-7. PubMed ID: 17283114 [TBL] [Abstract][Full Text] [Related]
29. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565 [TBL] [Abstract][Full Text] [Related]
30. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268 [TBL] [Abstract][Full Text] [Related]
31. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. Duran-Sandoval D; Cariou B; Percevault F; Hennuyer N; Grefhorst A; van Dijk TH; Gonzalez FJ; Fruchart JC; Kuipers F; Staels B J Biol Chem; 2005 Aug; 280(33):29971-9. PubMed ID: 15899888 [TBL] [Abstract][Full Text] [Related]
32. Farnesoid X Receptor Activation Promotes Hepatic Amino Acid Catabolism and Ammonium Clearance in Mice. Massafra V; Milona A; Vos HR; Ramos RJJ; Gerrits J; Willemsen ECL; Ramos Pittol JM; Ijssennagger N; Houweling M; Prinsen HCMT; Verhoeven-Duif NM; Burgering BMT; van Mil SWC Gastroenterology; 2017 May; 152(6):1462-1476.e10. PubMed ID: 28130067 [TBL] [Abstract][Full Text] [Related]
33. The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. Landrier JF; Eloranta JJ; Vavricka SR; Kullak-Ublick GA Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G476-85. PubMed ID: 16269519 [TBL] [Abstract][Full Text] [Related]
34. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. Cariou B Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631 [TBL] [Abstract][Full Text] [Related]
35. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy. Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826 [TBL] [Abstract][Full Text] [Related]
36. The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR. Porez G; Gross B; Prawitt J; Gheeraert C; Berrabah W; Alexandre J; Staels B; Lefebvre P Endocrinology; 2013 Oct; 154(10):3690-701. PubMed ID: 23861371 [TBL] [Abstract][Full Text] [Related]
37. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Zhang Y; Lee FY; Barrera G; Lee H; Vales C; Gonzalez FJ; Willson TM; Edwards PA Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1006-11. PubMed ID: 16410358 [TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition. Renga B; Mencarelli A; D'Amore C; Cipriani S; Baldelli F; Zampella A; Distrutti E; Fiorucci S FASEB J; 2012 Jul; 26(7):3021-31. PubMed ID: 22447981 [TBL] [Abstract][Full Text] [Related]
39. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Claudel T; Staels B; Kuipers F Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564 [TBL] [Abstract][Full Text] [Related]
40. Human kininogen gene is transactivated by the farnesoid X receptor. Zhao A; Lew JL; Huang L; Yu J; Zhang T; Hrywna Y; Thompson JR; de Pedro N; Blevins RA; Peláez F; Wright SD; Cui J J Biol Chem; 2003 Aug; 278(31):28765-70. PubMed ID: 12761213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]